https://twitter.com/jamapediatrics/status/1574519182624190464
Trace amounts of #COVID19 vaccine mRNAs were detected in the breast milk of some lactating women.Caution is warranted regarding #breastfeeding infants younger than six months in the first two days after maternal COVID-19 vaccination. #Research https://ja.ma/3UIKEjS #Research
Detection of Messenger RNA COVID-19 Vaccines in Human Breast Milk
https://jamanetwork.com/journals/jamapediatrics/fullarticle/2796427?guestAccessKey=1c13d17c-1c25-4828-b261-9f321e5126a1&utm_source=twitter&utm_medium=social_jamapeds&utm_term=7701881843&utm_campaign=article_alert&linkId=183092079
Vaccination is a cornerstone in fighting the COVID-19 pandemic. However, the initial messenger RNA (mRNA) vaccine clinical trials excluded several vulnerable groups, including young children and lactating individuals.1 The US Food and Drug Administration deferred the decision to authorize COVID-19 mRNA vaccines for infants younger than 6 months until more data are available because of the potential priming of the children’s immune responses that may alter their immunity.2 The Centers for Disease Control and Prevention recommends offering the COVID-19 mRNA vaccines to breastfeeding individuals,3 although the possible passage of vaccine mRNAs in breast milk resulting in infants’ exposure at younger than 6 months was not investigated. This study investigated whether the COVID-19 vaccine mRNA can be detected in the expressed breast milk (EBM) of lactating individuals receiving the vaccination within 6 months after delivery.
Results
Of 11 lactating individuals enrolled, trace amounts of BNT162b2 and mRNA-1273 COVID-19 mRNA vaccines were detected in 7 samples from 5 different participants at various times up to 45 hours postvaccination (Table 2). The mean (SD) yield of EVs isolated from EBM was 9.110 (5.010) particles/mL, and the mean (SD) particle size was 110.0 (3.0) nm. The vaccine mRNA appears in higher concentrations in the EVs than in whole milk (Table 2). No vaccine mRNA was detected in prevaccination or postvaccination EBM samples beyond 48 hours of collection. Also, no COVID-19 vaccine mRNA was detected in the EBM fat fraction or the EBM cell pellets.